Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2089-21-6

2089-21-6

Post Buying Request

2089-21-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2089-21-6 Usage

Class

Synthetic stimulant drug

Family

Cathinone class

Psychoactive Effects

Euphoria, increased energy, enhanced mood

Structural Relation

Related to cathinone, a naturally occurring stimulant in the khat plant

Consumption Methods

Oral, nasal, or intravenous

Adverse Effects

Increased heart rate, sweating, agitation, anxiety, hallucinations

Legal Status

Classified as a controlled substance in various countries

Potential Issues

Abuse and addiction risks

Check Digit Verification of cas no

The CAS Registry Mumber 2089-21-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,0,8 and 9 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2089-21:
(6*2)+(5*0)+(4*8)+(3*9)+(2*2)+(1*1)=76
76 % 10 = 6
So 2089-21-6 is a valid CAS Registry Number.

2089-21-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[4-(2-Morpholin-4-ylethoxy)phenyl]propan-1-one

1.2 Other means of identification

Product number -
Other names 1-[4-(2-morpholino-ethoxy)-phenyl]-propan-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2089-21-6 SDS

2089-21-6Relevant articles and documents

Identification, design and biological evaluation of heterocyclic quinolones targeting plasmodium falciparum Type II NADH:Quinone oxidoreductase (PfNDH2)

Leung, Suet C.,Gibbons, Peter,Amewu, Richard,Nixon, Gemma L.,Pidathala, Chandrakala,Hong, W. David,Pacorel, Bénédicte,Berry, Neil G.,Sharma, Raman,Stocks, Paul A.,Srivastava, Abhishek,Shone, Alison E.,Charoensutthivarakul, Sitthivut,Taylor, Lee,Berger, Olivier,Mbekeani, Alison,Hill, Alasdair,Fisher, Nicholas E.,Warman, Ashley J.,Biagini, Giancarlo A.,Ward, Stephen A.,O'Neill, Paul M.

supporting information; experimental part, p. 1844 - 1857 (2012/05/05)

Following a program undertaken to identify hit compounds against NADH:ubiquinone oxidoreductase (PfNDH2), a novel enzyme target within the malaria parasite Plasmodium falciparum, hit to lead optimization led to identification of CK-2-68, a molecule suitab

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2089-21-6